Haemophilia B, severe childhood obesity and other extra‐haematological features associated with similar 4Mb‐deletions on Xq27: Clinical findings, molecular insights and literature update

Autor: Claudia P. Radic, Miguel M. Abelleyro, Betiana Ziegler, Vanina D. Marchione, Julián Nevado, Pablo Lapunzina, Gabriela Sciuccati, Daniela Neme, Liliana C. Rossetti, Mariana Bonduel, Carlos D. De Brasi

Publikováno v: Haemophilia. 29:844-854

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f1b71314a22f1c6044b942cac4a175e
https://doi.org/10.1111/hae.14779

A multicentre real-world data study to assess the bleeding rate and management of patients with haemophilia A and factor VIII inhibitors in Argentina

Autor: Isabel Ramos Mejía, Patricia Do Nascimento, Ludmila Elelhou, Victoria Saenz, Maria E. Arrieta, Mauro Davoli, Andrea Cocca, Daniela Neme

Publikováno v: Blood Coagulation & Fibrinolysis. 32:564-571

The development of inhibitors against factor VIII (FVIII) concentrates is a severe complication of treatment for patients with haemophilia. We investigated annualized bleeding rates (ABRs) in patients in Argentina with haemophilia A with inhibitors a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a5882a58b383c0153ae4b368dc2a6e
https://doi.org/10.1097/mbc.0000000000001077

Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis

Autor: Martín Rossi, María Eulalia Landro, Carla Daffunchio, Mauro Andreu, Daniela Neme, Gustavo Galatro, Horacio Caviglia

Publikováno v: Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 27(4)

Introduction Primary prophylaxis is the current gold standard in haemophilia care for the prevention of bleeding and ensuing joint damage. Early detection of joint bleeding, whether symptomatic or subclinical, preferably during childhood, helps preve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe0b0dd2182e55ebcf60dd85f291dd0
https://pubmed.ncbi.nlm.nih.gov/33970513

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review

Autor: Jacky K. Yu, Alfonso Iorio, Andrea N. Edginton, Sanjay Ahuja, Ma Teresa Álvarez Román, Ma E. Arrieta, Mikko Arola, Giovanni Barillari, Vinod Balasa, Mark Belletrutti, Ruben Berrueco Moreno, Philippe Beurrier, Cristoph Bidlingmaier, Victor Blanchette, Jan Blatny, Santiago Bonanad, Kelsey Brose, Deborah Brown, Paulette C. Byant, Mariana Canaro, Manuela Carvalho, Cristina Catarino, Meera Chitlur, Erin Cockrell, Pratima Chowdary, Marjon Cnossen, Peter Collins, Michial Coppens, Stacy Croteau, Dorina Cultrera, Raimundo de Cristofaro, Emmauelle de Raucourt, Dominique Desprez, Amy Dunn, Magda El‐Ekiabi, Barbara Faganel Kotnik, Kathleen Fischer, Brigit Frotscher, Susana Garbiero, Raquel Garrido Ruiz, Joan Gill, Carmen Gomez del Castillo, Saskia Gottstein, Giuseppe Lassandro, Paola Giordano, Daniel Hart, Inga Hegemann, Cedric Hermans, Baolai Hua, Nina Hwang, Shannon Jackson, Paula James, Olga Katsarou, Kaan Kavakli, Christine Kempton, Karim Kentouche, Osman Khan, Rainer Kobelt, Rebecca Kruse‐Jarres, Edward Laane, Eric Larson, Riitta Lassila, Adrienne Lee, Man‐Chiu Poon, Jennifer Lissick, Satu Langstrom, Johnny Mahlangu, Michael Makris, Emmanuela Marchesini, Jose Mateo, Pacual Marco Vera, Marta Martorell, Tadashi Matsushita, Simon McCrae, Eva Mignot‐Castellano, Caitlin Montcrieff, Philip Maes, Veerle Mondelars, Marlies Bekart, Elena Mora, Juan Cristóbal Morales, Guillaume Mourey, Marie Ann Bertrand, Mariasanta Napolitano, Sergio Siragusa, Claude Negrier, Daniela Neme, Ritta Niinimaki, Johannes Oldenburg, Thilo Albert, Deborah Ornstein, Margarete Ozelo, John Carl Panetta, Ellis J. Neufeld, Stephanie P'Ng, Kathelijne Peerlinck, Berardino Pollio, Claire Pouplard, Yves Gruel, Alessandra Prezotti, Vicky Price, Fitri Primacakti, Mathieu Puyade, Paolo Radossi, Leslie Raffini, Margaret Ragni, Savita Rangarajan, Mark T. Reding, Robin Reid, Jose Restrepo, Jose Ramirez, Michael Recht, Manuel Rodriguez Lopez, Arlette Ruiz‐Sàez, Mahasen Saleh, Amy Shapiro, Anjali Sharathkumar, Anna Selmeczi, Mindy Simpson, Tami Singleton, Maria Sol Cruz, Veronica Soto, MacGregor Steele, Werner Streif, Hao Wei Sun, Bruce Ritchie, Jing Sun, Xiaqin Feng, Takashi Suzuki, Asuza Nagao, Cliff Takemoto, Heather Tapp, Jerry Teitel, Alan Tinmouth, Courtney Thornburg, Alberto Tosseto, Oliver Turnstall, Catherine Vezina, Beth Warren, Allison Wheeler, Juan D. Wilches Gutierrez, John K.M. Wu, Tung Wynn, Renchi Yang, Guy Young, Ezio Zanon, Irena Zupan

Publikováno v: Research and practice in thrombosis and haemostasis, Vol. 3, no.3, p. 528-541 (2019)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 528-541 (2019)

The objective of this scoping review is to summarize the current use of pharmacokinetics for tailoring prophylaxis in hemophilia patients switching between clotting factor products. Patients with hemophilia may require switching of clotting factor co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8855ec59f7541838e90c9de25930d966
https://hdl.handle.net/2078.1/224098

Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study

Autor: Gary Benson, Marek Zak, Mehran Karimi, F. Demartis, Hervé Chambost, Daniela Neme, Peyman Eshghi, L. Sommer, Kaan Kavakli

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 23(4)

Introduction A room temperature stable formulation of recombinant activated factor VII (NovoSeven® ), allowing convenient storage and therefore improved treatment access, has been developed. Bioequivalence to the previous NovoSeven® was demonstrate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3608003e382abce0b2162533f2cef39
https://pubmed.ncbi.nlm.nih.gov/28440004